作者：
Jiro,Kikuchi [1]
;
Mitsuo,Hori [2]
;
Naoki,Osada [3]
;
Sae,Matsuoka [3]
;
Atsushi,Suzuki [4]
;
Satoshi,Kakugawa [4]
;
Hiroshi,Yasui [5]
;
Takeshi,Harada [6]
;
Hirofumi,Tenshin [7]
;
Masahiro,Abe [8]
;
Hideki,Nakasone [3]
;
Yusuke,Furukawa [9]
作者单位：
Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498. kiku-j@jichi.ac.jp.
[1]
Department of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki 309-1793.
[2]
Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498.
[3]
Oncology Division, Bristol-Myers Squibb K.K., Shinjuku, Tokyo 163-1327.
[4]
The Institute of Medical Science, The University of Tokyo, Minato, Tokyo 108-8639, Japan; Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511 Japan.
[5]
Department of Hematology, University of Tokushima, Tokushima 770-8503.
[6]
Department of Orthodontics and Dentofacial Orthopedics, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8504.
[7]
Department of Hematology, Kawashima Hospital, Tokushima 770-0011.
[8]
Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan; Center for Medical Education, Teikyo University of Science, Tokyo 120-0045.
[9]
DOI
10.3324/haematol.2024.285368
PMID
38867588
发布时间
2024-10-03
换一批
换一批
